There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Title(s) as Introduced

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To make hemp, cannabidiol derived from hemp, and any other ingredient derived from hemp lawful for use under the Federal Food, Drug, and Cosmetic Act as a dietary ingredient in a dietary supplement, and for other purposes.


Actions Overview (1)

Date Actions Overview
02/04/2021Introduced in House

All Actions (3)

Date All Actions
02/05/2021Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
02/04/2021Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
02/04/2021Introduced in House
Action By: House of Representatives

Cosponsors (26)


Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Related Documents
House Energy and Commerce02/04/2021 Referred to
House Energy and Commerce Subcommittee on Health02/05/2021 Referred to

As of 06/14/2021 no related bill information has been received for H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021


Subjects (5)


Latest Summary (1)

There is one summary for H.R.841. View summaries

Shown Here:
Introduced in House (02/04/2021)

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021

This bill allows the use of hemp, cannabidiol (i.e., CBD) derived from hemp, or any other ingredient derived from hemp in a dietary supplement, provided that the supplement meets other applicable requirements. (Currently, the Food and Drug Administration's position is that CBD products may not be sold as dietary supplements.)